- Reported transaction lines
- 12
- Buy lines
- 0
- Sell lines
- 0
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-1112
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Restricted Stock Unit · Derivative security · Direct ownership · Reported balance after transaction: 174354 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · This restricted stock units award vests with respect to 1/12 of the award in quarterly installments on November 15, 2026 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date. · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 15,850 shares/units | SEC 4 |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Restricted Stock Unit · Derivative security · Direct ownership · Reported balance after transaction: 25568 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · This restricted stock units award vests with respect to 1/8 of the award in quarterly installments on May 15, 2025 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date. · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 25,567 shares/units | SEC 4 |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Restricted Stock Unit · Derivative security · Direct ownership · Reported balance after transaction: 57527 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on May 15, 2025 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date. · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 6,392 shares/units | SEC 4 |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Restricted Stock Unit · Derivative security · Direct ownership · Reported balance after transaction: 12848 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on August 15, 2023 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date. · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 6,424 shares/units | SEC 4 |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Other transactionFiling detailsSEC transaction code F Class A Common Stock · Direct ownership · Reported balance after transaction: 101202 · Securities delivered or withheld for tax or exercise payment · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 6,951 shares/units | SEC 4 |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Class A Common Stock · Direct ownership · Reported balance after transaction: 108153 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 15,850 shares/units | SEC 4 |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Other transactionFiling detailsSEC transaction code F Class A Common Stock · Direct ownership · Reported balance after transaction: 92303 · Securities delivered or withheld for tax or exercise payment · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 11,212 shares/units | SEC 4 |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Class A Common Stock · Direct ownership · Reported balance after transaction: 103515 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 25,567 shares/units | SEC 4 |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Other transactionFiling detailsSEC transaction code F Class A Common Stock · Direct ownership · Reported balance after transaction: 77948 · Securities delivered or withheld for tax or exercise payment · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 2,803 shares/units | SEC 4 |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Class A Common Stock · Direct ownership · Reported balance after transaction: 80751 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 6,392 shares/units | SEC 4 |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Other transactionFiling detailsSEC transaction code F Class A Common Stock · Direct ownership · Reported balance after transaction: 74359 · Securities delivered or withheld for tax or exercise payment · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 2,817 shares/units | SEC 4 |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Class A Common Stock · Direct ownership · Reported balance after transaction: 77176 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 6,424 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.